Quantcast
Last updated on April 24, 2014 at 1:21 EDT

Latest Becton Dickinson Stories

2013-02-28 08:29:52

Blood Culture Systems Comparison Study Shows BD BACTEC(TM) Plus Aerobic Medium Provides Statistically Significant Differences in Bacterial Recovery for Patients on Antimicrobial Therapy BALTIMORE, Feb. 28, 2013 /PRNewswire/ -- A new study, published in the journal Clinical Infectious Diseases, demonstrates how treatment with broad-spectrum antibiotics can impact the ability to detect bacteria in blood samples from potentially septic patients. It also highlights the importance of...

2013-02-22 23:04:25

“Patient Examination Devices Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2018”, “Sterilization and Disinfectant Equipment Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2018” and “Sterilization and Disinfectant Equipment Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2018” new market research reports added to ReportsnReports.com store. Dallas, Texas (PRWEB) February 22, 2013...

2013-02-21 08:32:54

NEW YORK, February 21, 2013 /PRNewswire/ -- Today, National Traders Association announced new research reports highlighting Bruker Corporation (NASDAQ: BRKR), Agilent Technologies Inc. (NYSE: A), General Electric Company (NYSE: GE), Becton, Dickinson and Co. (NYSE: BDX) and Thermo Fisher Scientific Inc. (NYSE: TMO). Today's readers may access these reports free of charge - including full price targets, industry analysis and analyst ratings - via the links below. Bruker...

2013-02-07 16:26:45

FRANKLIN LAKES, N.J., Feb. 7, 2013 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today that it will present at the following investor healthcare conferences in February 2013: Leerink Swann Global Healthcare Conference 2013February 14, 20132:00 p.m. ET 2013 Citi Global Healthcare ConferenceFebruary 26, 20138:00 a.m. ET 2013 RBC Capital Markets' Healthcare ConferenceFebruary 27, 201311:30 a.m. ET Live webcasts of BD's...

2013-02-05 08:33:20

FRANKLIN LAKES, N.J., Feb. 5, 2013 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today reported quarterly revenues of $1.90 billion for the first fiscal quarter ended December 31, 2012, representing an increase of 3.7 percent from the prior-year period, or 5.2 percent on a foreign currency-neutral basis. "We are very pleased with our start to fiscal year 2013," said Vincent A. Forlenza, Chairman, Chief Executive Officer and...

2013-01-29 16:23:50

FRANKLIN LAKES, N.J., Jan. 29, 2013 /PRNewswire/ -- The Board of Directors of BD (Becton, Dickinson and Company) (NYSE: BDX) has declared a quarterly dividend of 49.5 cents per common share, payable on March 29, 2013 to holders of record on March 8, 2013. The indicated annual dividend rate is $1.98 per share. About BDBD is a leading global medical technology company that develops, manufactures and sells medical devices, instrument systems and reagents. The Company is dedicated to improving...

2013-01-29 16:23:47

FRANKLIN LAKES, N.J., Jan. 29, 2013 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE:BDX), a leading global medical technology company, announced that Catherine M. Burzik has been elected to its Board of Directors. Ms. Burzik, 62, is a seasoned healthcare executive with leadership experience in medical device, diagnostic, diagnostic imaging and life sciences businesses. Most recently, from 2006 until the sale of the company in 2012, she served as President, Chief Executive Officer...

2013-01-23 16:24:21

FRANKLIN LAKES, N.J., Jan. 23, 2013 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a global medical technology company, announced today that it will host a live webcast of its Annual Meeting of Shareholders on Tuesday, January 29, 2013, at 1 p.m. (ET). The webcast can be accessed from the BD corporate website at http://www.bd.com/investors and will be available for replay through Tuesday, February 5, 2013. About BDBD is a leading global medical technology company that...

2013-01-15 08:24:19

FRANKLIN LAKES, N.J., Jan. 15, 2013 /PRNewswire/ -- BD Medical, a segment of BD (Becton, Dickinson and Company) (NYSE:BDX), a leading global medical technology company, today announced that the U.S. Food and Drug Administration (FDA) has cleared the BD PhaSeal(TM) Closed System Transfer Device (CSTD) under the newly created ONB code. The BD PhaSeal System is the first and only cleared CSTD under the new code, which was created for devices that have specific indications for use with...

2013-01-08 16:23:48

FRANKLIN LAKES, N.J., Jan. 8, 2013 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX) announced today that it will conduct a live webcast of its first fiscal quarter 2013 earnings conference call on Tuesday, February 5, 2013, at 8:00 a.m. (ET). BD will issue a press release detailing the quarter's earnings earlier that morning. The webcast of the conference call, along with related slides, will be accessible through BD's website at www.bd.com/investors and will be available...